Home » Author Archive

Comparing Alphabet (NASDAQ:GOOG) & Chinanet Online (NASDAQ:CNET)

Alphabet (NASDAQ:GOOG) and Chinanet Online (NASDAQ:CNET) are both computer and technology companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, valuation, risk, institutional ownership, earnings, analyst recommendations and dividends. Earnings & Valuation This table compares Alphabet and Chinanet Online’s revenue, earnings per share and valuation. Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Alphabet $136.82 billion 6.79 $30.74... 
 

BidaskClub Upgrades Monster Beverage (NASDAQ:MNST) to Hold

BidaskClub upgraded shares of Monster Beverage (NASDAQ:MNST) from a sell rating to a hold rating in a research note published on Thursday morning, BidAskClub reports. Other equities research analysts also recently issued reports about the stock. Wells Fargo & Co reduced their price objective on shares of Monster Beverage from $59.00 to $58.00 and set a market perform rating on the stock in a research note on Tuesday, October 15th. Guggenheim downgraded shares of Monster Beverage from a buy rating to a neutral rating and reduced their price objective... 
 

LivaNova (NASDAQ:LIVN) Cut to Hold at BidaskClub

BidaskClub cut shares of LivaNova (NASDAQ:LIVN) from a buy rating to a hold rating in a research note published on Thursday morning, BidAskClub reports. Other analysts also recently issued research reports about the stock. Piper Jaffray Companies set a $90.00 price objective on shares of LivaNova and gave the stock a buy rating in a research report on Friday, September 6th. Zacks Investment Research downgraded shares of LivaNova from a strong-buy rating to a hold rating in a research report on Wednesday, October 2nd. Stifel Nicolaus raised their... 
 

Integrafin’s (IHP) “Add” Rating Reiterated at Peel Hunt

Integrafin (LON:IHP)‘s stock had its “add” rating reaffirmed by research analysts at Peel Hunt in a research report issued to clients and investors on Monday, ThisIsMoney.Co.Uk reports. Separately, Berenberg Bank began coverage on Integrafin in a research report on Thursday, November 21st. They set a “buy” rating and a GBX 460 ($6.05) target price for the company. LON:IHP opened at GBX 420.50 ($5.53) on Monday. Integrafin has a 12-month low of GBX 265.05 ($3.49) and a 12-month high of GBX 412 ($5.42). The stock has... 
 

Hunting (LON:HTG) Rating Reiterated by UBS Group

Hunting (LON:HTG)‘s stock had its “buy” rating restated by research analysts at UBS Group in a report released on Monday, ThisIsMoney.Co.Uk reports. A number of other research firms also recently weighed in on HTG. Barclays lowered their target price on Hunting from GBX 530 ($6.97) to GBX 500 ($6.58) and set an “equal weight” rating on the stock in a report on Friday. Goldman Sachs Group downgraded Hunting to a “sell” rating and lowered their target price for the company from GBX 602 ($7.92) to GBX 385 ($5.06)... 
 

SThree (LON:STHR) Stock Rating Reaffirmed by UBS Group

SThree (LON:STHR)‘s stock had its “buy” rating restated by stock analysts at UBS Group in a research report issued to clients and investors on Monday, ThisIsMoney.Co.Uk reports. Separately, Liberum Capital reissued a “buy” rating on shares of SThree in a research note on Thursday. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus price target of GBX 395 ($5.20). STHR... 
 

Boingo Wireless Inc (NASDAQ:WIFI) Short Interest Down 8.5% in November

Boingo Wireless Inc (NASDAQ:WIFI) was the recipient of a large drop in short interest in the month of November. As of November 29th, there was short interest totalling 4,320,000 shares, a drop of 8.5% from the November 14th total of 4,720,000 shares. Approximately 10.2% of the shares of the stock are sold short. Based on an average trading volume of 646,200 shares, the short-interest ratio is currently 6.7 days. Shares of WIFI opened at $11.42 on Monday. Boingo Wireless has a 52-week low of $8.85 and a 52-week high of $26.07. The business’s... 
 

Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) Short Interest Up 10.0% in November

Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) was the target of a large increase in short interest during the month of November. As of November 29th, there was short interest totalling 5,040,000 shares, an increase of 10.0% from the November 14th total of 4,580,000 shares. Currently, 24.9% of the company’s stock are short sold. Based on an average trading volume of 680,600 shares, the short-interest ratio is currently 7.4 days. A number of institutional investors and hedge funds have recently modified their holdings of the business. Bernardo... 
 

Atlas Air Worldwide (NASDAQ:AAWW) Upgraded at BidaskClub

BidaskClub upgraded shares of Atlas Air Worldwide (NASDAQ:AAWW) from a sell rating to a hold rating in a research note released on Thursday, BidAskClub reports. Other equities research analysts have also recently issued research reports about the company. Wolfe Research upgraded Atlas Air Worldwide from an underperform rating to a peer perform rating in a report on Friday, October 4th. Susquehanna Bancshares cut Atlas Air Worldwide from a positive rating to a neutral rating and dropped their price objective for the stock from $43.00 to $30.00 in... 
 

Derwent London (LON:DLN) Stock Rating Reaffirmed by JPMorgan Chase & Co.

JPMorgan Chase & Co. reiterated their underweight rating on shares of Derwent London (LON:DLN) in a research report report published on Thursday morning, ThisIsMoney.Co.Uk reports. DLN has been the topic of a number of other reports. Peel Hunt restated a hold rating on shares of Derwent London in a research report on Tuesday, December 3rd. Goldman Sachs Group raised their price target on shares of Derwent London from GBX 3,269 ($43.00) to GBX 3,722 ($48.96) and gave the company a neutral rating in a research note on Tuesday, December 10th.... 
 

Jumia Technologies (NYSE:JMIA) Lowered to Hold at Zacks Investment Research

Zacks Investment Research cut shares of Jumia Technologies (NYSE:JMIA) from a buy rating to a hold rating in a research note released on Thursday morning, Zacks.com reports. According to Zacks, “Jumia Technologies AG provides e-commerce services. The Company offers products, which includes dresses, leggings, skirts, polo shirts, belts, watches, sunglasses, health products, beauty products and a range of products for children, among others. Jumia Technologies AG is based in Berlin, Germany. “ A number of other equities analysts also... 
 

Metro Bank (OTCMKTS:MBNKF) Downgraded to Sell at Zacks Investment Research

Zacks Investment Research cut shares of Metro Bank (OTCMKTS:MBNKF) from a hold rating to a sell rating in a research report sent to investors on Thursday morning, Zacks.com reports. According to Zacks, “Metro Bank PLC is a commercial bank which provides banking products and services to retail and institutional customers. The company offers current accounts, loans, mortgages, safe deposit boxes, cash management, private banking and debit and credit cards. Metro Bank PLC is based in London, United Kingdom. “ A number of other research... 
 

Stagecoach Group (LON:SGC) Rating Reiterated by Deutsche Bank

Deutsche Bank reiterated their buy rating on shares of Stagecoach Group (LON:SGC) in a research report released on Thursday, Stock Target Advisor reports. A number of other research analysts also recently issued reports on SGC. Liberum Capital downgraded shares of Stagecoach Group to a hold rating in a research report on Wednesday, December 11th. Canaccord Genuity restated a hold rating and issued a GBX 150 ($1.97) price target on shares of Stagecoach Group in a research report on Friday, October 25th. One research analyst has rated the stock... 
 

Zacks Investment Research Upgrades LendingClub (NYSE:LC) to Buy

Zacks Investment Research upgraded shares of LendingClub (NYSE:LC) from a hold rating to a buy rating in a report published on Thursday morning, Zacks.com reports. Zacks Investment Research currently has $14.00 price objective on the credit services provider’s stock. According to Zacks, “LendingClub Corporation provides internet financial services. The Company offers online marketplace for loan approval, pricing, servicing and support operations as well as regulatory and legal framework which connects borrowers and investors. LendingClub... 
 

Analyzing ViacomCBS (VIAC) & Its Rivals

ViacomCBS (NASDAQ: VIAC) is one of 24 publicly-traded companies in the “Television broadcasting stations” industry, but how does it contrast to its peers? We will compare ViacomCBS to similar companies based on the strength of its risk, profitability, earnings, institutional ownership, analyst recommendations, valuation and dividends. Earnings & Valuation This table compares ViacomCBS and its peers top-line revenue, earnings per share and valuation. Gross Revenue Net Income Price/Earnings Ratio ViacomCBS $14.51 billion $1.96... 
 

Wyndham Destinations (NYSE:WYND) Rating Lowered to Hold at Zacks Investment Research

Zacks Investment Research cut shares of Wyndham Destinations (NYSE:WYND) from a buy rating to a hold rating in a research note released on Thursday, Zacks.com reports. According to Zacks, “Wyndham Destinations, Inc. operates as a hospitality company. It offers hotel management and vacation exchange and rental services, as well as develops, markets and sells vacation ownership interests to individual consumers. The Company franchises hotels in the upscale, midscale, and economy segments of the lodging industries. Wyndham Destinations, Inc.,... 
 

Toronto-Dominion Bank (NYSE:TD) Lowered to Sell at Zacks Investment Research

Zacks Investment Research lowered shares of Toronto-Dominion Bank (NYSE:TD) (TSE:TD) from a hold rating to a sell rating in a research note published on Thursday morning, Zacks.com reports. According to Zacks, “Toronto Dominion Bank is a Canadian chartered bank and offers a wide range of business and consumer services. These services include checking and savings accounts, credit cards, mortgage and student loans,trusts, wills, estate planning,investment management services and financial and advisory services. “ Other analysts have... 
 

Broadcom’s (AVGO) Hold Rating Reiterated at Raymond James

Raymond James reaffirmed their hold rating on shares of Broadcom (NASDAQ:AVGO) in a research note published on Thursday, TipRanks reports. Several other equities analysts have also recently issued reports on AVGO. BidaskClub upgraded Broadcom from a buy rating to a strong-buy rating in a research note on Friday. Mizuho reaffirmed a buy rating and issued a $365.00 target price (up from $340.00) on shares of Broadcom in a research report on Thursday. ValuEngine raised Broadcom from a sell rating to a hold rating in a research report on Wednesday,... 
 

Daimler (ETR:DAI) PT Set at €45.00 by HSBC

HSBC set a €45.00 ($52.33) target price on Daimler (ETR:DAI) in a research report released on Thursday morning, Borsen Zeitung reports. The brokerage currently has a sell rating on the stock. Several other research analysts have also weighed in on DAI. Royal Bank of Canada set a €62.00 ($72.09) price objective on Daimler and gave the stock a buy rating in a research report on Friday, November 29th. Independent Research set a €53.00 ($61.63) price objective on Daimler and gave the stock a neutral rating in a research report on Friday,... 
 

Amneal Pharmaceuticals (NYSE:AMRX) Downgraded to Market Perform at Raymond James

Raymond James downgraded shares of Amneal Pharmaceuticals (NYSE:AMRX) from an outperform rating to a market perform rating in a report released on Thursday, Benzinga reports. A number of other research analysts also recently weighed in on AMRX. ValuEngine raised Amneal Pharmaceuticals from a hold rating to a buy rating in a research note on Monday, November 25th. Guggenheim assumed coverage on Amneal Pharmaceuticals in a research note on Thursday, September 12th. They issued a sell rating and a $2.50 price objective on the stock. JPMorgan Chase... 
 

Y-mAbs Therapeutics (NASDAQ:YMAB) Receives New Coverage from Analysts at Cowen

Cowen initiated coverage on shares of Y-mAbs Therapeutics (NASDAQ:YMAB) in a research note issued to investors on Thursday morning, Stock Target Advisor reports. The brokerage issued a buy rating on the stock. Other equities analysts have also recently issued reports about the stock. Zacks Investment Research cut shares of Y-mAbs Therapeutics from a buy rating to a hold rating in a report on Thursday, November 21st. ValuEngine cut shares of Y-mAbs Therapeutics from a hold rating to a sell rating in a research note on Wednesday, December 11th. HC... 
 

Guaranty Bancshares (NASDAQ:GNTY) Upgraded at TheStreet

TheStreet upgraded shares of Guaranty Bancshares (NASDAQ:GNTY) from a c rating to a b- rating in a research note issued to investors on Thursday morning, TheStreetRatingsTable reports. Several other equities analysts have also recently issued reports on the company. Stephens restated a buy rating and set a $35.00 price objective on shares of Guaranty Bancshares in a research note on Tuesday, October 22nd. Zacks Investment Research cut Guaranty Bancshares from a buy rating to a hold rating in a research note on Tuesday, November 12th. Keefe, Bruyette... 
 

Zomedica Pharmaceuticals Corp (NYSEAMERICAN) (NYSE:ZOM) Lowered to Sell at Zacks Investment Research

Zacks Investment Research downgraded shares of Zomedica Pharmaceuticals Corp (NYSEAMERICAN) (NYSE:ZOM) from a hold rating to a sell rating in a report published on Thursday morning, Zacks.com reports. According to Zacks, “Zomedica Pharmaceuticals Corp. is a veterinary pharmaceutical and health care solutions company. It provides products for companion animals by focusing on the unmet needs of clinical veterinarians. The company’s portfolio includes diagnostics, devices, innovative drugs and drug-delivery technologies. Zomedica Pharmaceuticals... 
 

CarMax (NYSE:KMX) Lowered to “Hold” at Zacks Investment Research

Zacks Investment Research cut shares of CarMax (NYSE:KMX) from a buy rating to a hold rating in a research report sent to investors on Thursday, Zacks.com reports. Zacks Investment Research currently has $104.00 price target on the stock. According to Zacks, “Shares of CarMax have outperformed the broader industry year to date. The company  has been benefitting from an aggressive store expansion initiative in existing as well as new television markets. Strong market presence through store expansion and robust demand for used vehicles... 
 

Akero Therapeutics (NASDAQ:AKRO) Downgraded to Sell at Zacks Investment Research

Zacks Investment Research cut shares of Akero Therapeutics (NASDAQ:AKRO) from a hold rating to a sell rating in a research report released on Thursday morning, Zacks.com reports. According to Zacks, “Akero Therapeutics Inc. is a clinical-stage biotechnology company. It is focused on developing transformational treatments for non-alcoholic steatohepatitis and other serious metabolic disorders. The company’s product pipeline consists of AKR-001, for the treatment of non-alcoholic steatohepatitis, which are in clinical stage. Akero Therapeutics... 
 

Alimera Sciences (NASDAQ:ALIM) Stock Rating Upgraded by Zacks Investment Research

Zacks Investment Research upgraded shares of Alimera Sciences (NASDAQ:ALIM) from a sell rating to a hold rating in a report published on Thursday, Zacks.com reports. According to Zacks, “Alimera Sciences, Inc., based in Alpharetta, Georgia, is a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. The Company is presently focused on diseases affecting the back of the eye, or retina because it believes these diseases are not well treated with current therapies... 
 

Somewhat Positive News Coverage Extremely Unlikely to Impact SPY (OTCMKTS:XSPY) Stock Price

News articles about SPY (OTCMKTS:XSPY) have been trending somewhat positive this week, according to InfoTrie. InfoTrie ranks the sentiment of media coverage by reviewing more than 6,000 blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. SPY earned a daily sentiment score of 1.73 on their scale. InfoTrie also assigned news articles about the company an news buzz score of 1 out of 10, indicating that recent media coverage is extremely... 
 

JPMorgan Chase & Co. Reiterates “€65.00” Price Target for Lanxess (ETR:LXS)

JPMorgan Chase & Co. set a €65.00 ($75.58) target price on Lanxess (ETR:LXS) in a report issued on Thursday morning, Borsen Zeitung reports. The brokerage currently has a neutral rating on the stock. A number of other research firms have also commented on LXS. Bank of America set a €66.00 ($76.74) price target on Lanxess and gave the stock a buy rating in a report on Monday, November 18th. Baader Bank set a €60.00 ($69.77) price target on Lanxess and gave the stock a neutral rating in a report on Monday, November 25th. UBS... 
 

South Mountain Merger Corp.’s Lock-Up Period To Expire Tomorrow (OTCMKTS:SMMCU)

South Mountain Merger’s (OTCMKTS:SMMCU) lock-up period will expire on Tuesday, December 17th. South Mountain Merger had issued 22,500,000 shares in its initial public offering on June 20th. The total size of the offering was $225,000,000 based on an initial share price of $10.00. After the end of South Mountain Merger’s lock-up period, major shareholders and company insiders will be able to sell their shares of the company. Shares of OTCMKTS:SMMCU opened at $10.23 on Monday. South Mountain Merger has a 12-month low of $9.95 and a 12-month... 
 

Personalis’ Lock-Up Period Will Expire Tomorrow (NASDAQ:PSNL)

Personalis’ (NASDAQ:PSNL) lock-up period is set to expire on Tuesday, December 17th. Personalis had issued 7,921,500 shares in its initial public offering on June 20th. The total size of the offering was $134,665,500 based on an initial share price of $17.00. After the end of Personalis’ lock-up period, major shareholders and company insiders will be able to sell their shares of the company. A number of brokerages have issued reports on PSNL. Oppenheimer reduced their price target on Personalis from $29.00 to $26.00 and set an “outperform”... 
 

K&S’s (SDF) Buy Rating Reaffirmed at DZ Bank

DZ Bank reaffirmed their buy rating on shares of K&S (ETR:SDF) in a research report report published on Thursday, Borsen Zeitung reports. A number of other equities research analysts also recently commented on the stock. Independent Research set a €12.70 ($14.77) target price on shares of K&S and gave the stock a neutral rating in a research report on Monday, November 18th. Credit Suisse Group set a €12.00 ($13.95) target price on shares of K&S and gave the stock a neutral rating in a research report on Friday, November... 
 

North American Construction Group (NYSE:NOA) Receiving Somewhat Critical Media Coverage, Analysis Shows

Press coverage about North American Construction Group (NYSE:NOA) (TSE:NOA) has trended somewhat negative this week, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive news coverage by analyzing more than 6,000 blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. North American Construction Group earned a media sentiment score of -1.92 on their scale. InfoTrie also gave media... 
 

Atreca’s Lock-Up Period To End Tomorrow (NASDAQ:BCEL)

Atreca’s (NASDAQ:BCEL) lock-up period is set to end on Tuesday, December 17th. Atreca had issued 7,350,000 shares in its IPO on June 20th. The total size of the offering was $124,950,000 based on an initial share price of $17.00. After the end of the company’s lock-up period, company insiders and major shareholders will be able to sell their shares of the company. BCEL has been the topic of several recent analyst reports. Brookline Capital Management reaffirmed a “buy” rating on shares of Atreca in a research note on Tuesday,... 
 

SkyWest, Inc. (NASDAQ:SKYW) Short Interest Up 6.2% in November

SkyWest, Inc. (NASDAQ:SKYW) saw a significant growth in short interest in the month of November. As of November 29th, there was short interest totalling 549,400 shares, a growth of 6.2% from the November 14th total of 517,500 shares. Based on an average daily volume of 202,500 shares, the short-interest ratio is presently 2.7 days. Approximately 1.1% of the company’s shares are short sold. A number of brokerages have issued reports on SKYW. Stephens began coverage on shares of SkyWest in a research note on Monday, November 4th. They set... 
 

South Plains Financial (NASDAQ:SPFI) Sees Significant Growth in Short Interest

South Plains Financial (NASDAQ:SPFI) saw a large growth in short interest during the month of November. As of November 29th, there was short interest totalling 34,900 shares, a growth of 6.1% from the November 14th total of 32,900 shares. Approximately 0.3% of the shares of the company are short sold. Based on an average daily trading volume, of 34,300 shares, the days-to-cover ratio is presently 1.0 days. SPFI opened at $19.76 on Monday. South Plains Financial has a 12-month low of $15.82 and a 12-month high of $19.99. The company has a debt-to-equity... 
 

Progress Software Corp (NASDAQ:PRGS) Short Interest Up 6.3% in November

Progress Software Corp (NASDAQ:PRGS) was the target of a large growth in short interest in the month of November. As of November 29th, there was short interest totalling 509,700 shares, a growth of 6.3% from the November 14th total of 479,400 shares. Based on an average daily volume of 279,300 shares, the days-to-cover ratio is currently 1.8 days. Approximately 1.2% of the shares of the company are sold short. A number of equities research analysts have recently commented on the stock. Wedbush reaffirmed an “outperform” rating and... 
 

Caesarstone Ltd (NASDAQ:CSTE) Sees Significant Increase in Short Interest

Caesarstone Ltd (NASDAQ:CSTE) was the target of a large growth in short interest in the month of November. As of November 29th, there was short interest totalling 204,300 shares, a growth of 6.0% from the November 14th total of 192,700 shares. Approximately 0.9% of the company’s shares are short sold. Based on an average daily trading volume, of 123,100 shares, the days-to-cover ratio is presently 1.7 days. Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Cardinal Capital Management... 
 

Washington Real Estate Investment Trust (NYSE:WRE) Short Interest Up 6.2% in November

Washington Real Estate Investment Trust (NYSE:WRE) was the target of a significant growth in short interest in the month of November. As of November 29th, there was short interest totalling 3,600,000 shares, a growth of 6.2% from the November 14th total of 3,390,000 shares. Currently, 4.5% of the shares of the company are sold short. Based on an average daily volume of 334,300 shares, the short-interest ratio is currently 10.8 days. Washington Real Estate Investment Trust stock opened at $29.60 on Monday. Washington Real Estate Investment Trust... 
 

Short Interest in Sutro Biopharma Inc (NASDAQ:STRO) Grows By 6.3%

Sutro Biopharma Inc (NASDAQ:STRO) saw a significant increase in short interest during the month of November. As of November 29th, there was short interest totalling 152,900 shares, an increase of 6.3% from the November 14th total of 143,900 shares. Based on an average daily volume of 52,900 shares, the days-to-cover ratio is currently 2.9 days. Approximately 1.8% of the company’s shares are short sold. Several analysts recently weighed in on the stock. Wedbush reissued an “outperform” rating on shares of Sutro Biopharma in a... 
 

Short Interest in Medpace Holdings Inc (NASDAQ:MEDP) Increases By 6.4%

Medpace Holdings Inc (NASDAQ:MEDP) saw a large increase in short interest during the month of November. As of November 29th, there was short interest totalling 2,340,000 shares, an increase of 6.4% from the November 14th total of 2,200,000 shares. Currently, 8.5% of the shares of the stock are sold short. Based on an average daily volume of 334,000 shares, the days-to-cover ratio is currently 7.0 days. In other Medpace news, General Counsel Stephen P. Ewald sold 8,000 shares of Medpace stock in a transaction on Friday, October 18th. The shares... 
 

Titan Medical Inc. (NASDAQ:TMDI) Short Interest Up 14.2% in November

Titan Medical Inc. (NASDAQ:TMDI) was the recipient of a large increase in short interest during the month of November. As of November 29th, there was short interest totalling 886,200 shares, an increase of 14.2% from the November 14th total of 775,900 shares. Currently, 2.6% of the shares of the stock are sold short. Based on an average trading volume of 641,800 shares, the short-interest ratio is currently 1.4 days. A number of equities research analysts recently commented on TMDI shares. Piper Jaffray Companies reissued a “buy”... 
 

Houlihan Lokey (NYSE:HLI) Raised to “Hold” at Zacks Investment Research

Zacks Investment Research upgraded shares of Houlihan Lokey (NYSE:HLI) from a sell rating to a hold rating in a research report released on Thursday, Zacks.com reports. According to Zacks, “Houlihan Lokey, Inc. is an investment bank which focuses on mergers and acquisitions, financings, financial restructurings and financial advisory services. The Company’s operating segments consist of Corporate Finance, encompassing M&A and capital markets advisory; Financial Restructuring both out-of-court and in formal bankruptcy or insolvency... 
 

Gossamer Bio (NASDAQ:GOSS) Downgraded by Zacks Investment Research

Zacks Investment Research lowered shares of Gossamer Bio (NASDAQ:GOSS) from a hold rating to a sell rating in a research note released on Thursday, Zacks.com reports. According to Zacks, “Gossamer Bio Inc. is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing and commercializing therapeutics in the areas of immunology, inflammation and oncology. The company’s product pipeline includes GB001, GB002, GB004, GB1275, Autoimmune program and Oncology program which are in clinical stage. Gossamer Bio... 
 

bluebird bio (NASDAQ:BLUE) Lifted to Outperform at Oppenheimer

Oppenheimer upgraded shares of bluebird bio (NASDAQ:BLUE) from a market perform rating to an outperform rating in a research report report published on Thursday, BenzingaRatingsTable reports. Oppenheimer currently has $135.00 price objective on the biotechnology company’s stock. Oppenheimer also issued estimates for bluebird bio’s FY2020 earnings at ($14.55) EPS, FY2021 earnings at ($11.90) EPS, FY2022 earnings at ($9.47) EPS and FY2023 earnings at ($6.98) EPS. Several other research analysts also recently commented on the stock. Svb... 
 

Zacks Investment Research Downgrades Mereo BioPharma Group (NASDAQ:MREO) to Sell

Mereo BioPharma Group (NASDAQ:MREO) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued to investors on Friday, Zacks.com reports. According to Zacks, “Mereo BioPharma Group PLC is a biopharmaceutical company. It is focused on development and commercialization of therapeutics for patients with rare diseases. The company’s product pipeline includes BPS-804, MPH-966, BCT-197, BGS-649, Navicixizumab and Etigilimab which are in clinical stage. Mereo BioPharma... 
 

iShares iBonds Dec 2029 Term Corporate ETF (NYSEARCA:IBDU) Trading 0.5% Higher

iShares iBonds Dec 2029 Term Corporate ETF (NYSEARCA:IBDU) traded up 0.5% during trading on Friday . The company traded as high as $25.47 and last traded at $25.47, 847 shares changed hands during mid-day trading. A decline of 93% from the average session volume of 11,481 shares. The stock had previously closed at $25.34. The firm has a 50-day simple moving average of $25.40. Featured Article: Why is the price target of stocks important?  Read More »
 

Merrimack Pharmaceuticals (NASDAQ:MACK) Downgraded by ValuEngine

ValuEngine cut shares of Merrimack Pharmaceuticals (NASDAQ:MACK) from a buy rating to a hold rating in a report issued on Thursday morning, ValuEngine reports. Shares of Merrimack Pharmaceuticals stock opened at $3.85 on Thursday. Merrimack Pharmaceuticals has a 52 week low of $3.51 and a 52 week high of $7.50. The business’s fifty day simple moving average is $3.99 and its 200-day simple moving average is $5.26. Merrimack Pharmaceuticals (NASDAQ:MACK) last announced its quarterly earnings results on Tuesday, November 12th. The biopharmaceutical... 
 

Inspire 100 ETF (BIBL) To Go Ex-Dividend on December 13th

Inspire 100 ETF (NYSEARCA:BIBL) announced a quarterly dividend on Friday, December 13th, Wall Street Journal reports. Investors of record on Monday, December 16th will be paid a dividend of 0.1037 per share on Monday, December 23rd. This represents a $0.41 annualized dividend and a yield of 1.40%. The ex-dividend date of this dividend is Friday, December 13th. This is an increase from Inspire 100 ETF’s previous quarterly dividend of $0.09. Shares of NYSEARCA:BIBL opened at $29.72 on Friday. Inspire 100 ETF has a 12 month low of $22.48 and... 
 

First Trust Small Cap Value AlphaDEX Fund (FYT) to Issue Quarterly Dividend of $0.17 on December 31st

First Trust Small Cap Value AlphaDEX Fund (NASDAQ:FYT) declared a quarterly dividend on Friday, December 13th, Wall Street Journal reports. Stockholders of record on Monday, December 16th will be paid a dividend of 0.1693 per share on Tuesday, December 31st. This represents a $0.68 annualized dividend and a dividend yield of 1.82%. The ex-dividend date of this dividend is Friday, December 13th. This is a positive change from First Trust Small Cap Value AlphaDEX Fund’s previous quarterly dividend of $0.10. First Trust Small Cap Value AlphaDEX... 
 

Bonpay Price Reaches $0.0065 on Exchanges (BON)

Bonpay (CURRENCY:BON) traded 0.4% higher against the dollar during the 24-hour period ending at 9:00 AM E.T. on December 15th. Over the last seven days, Bonpay has traded down 5.7% against the dollar. Bonpay has a total market capitalization of $72,871.00 and approximately $1,828.00 worth of Bonpay was traded on exchanges in the last 24 hours. One Bonpay token can currently be bought for about $0.0065 or 0.00000091 BTC on popular exchanges including Mercatox, CoinExchange, Cryptopia and C-CEX. Here’s how related cryptocurrencies have... 
 
© 2006-2019 Ticker Report